Current Attempt in Progress Amy Dyken, controller at Crane Pharmaceutical Industries, a public company, is currently...
Fantastic news! We've Found the answer you've been seeking!
Question:
Transcribed Image Text:
Current Attempt in Progress Amy Dyken, controller at Crane Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Crane's financial statements. Below is selected financial information for the fiscal year ended June 30, 2025. Long-term debt Notes payable, 11% 9% convertible bonds payable 11% bonds payable Total long-term debt Crane Pharmaceutical Industries Selected Balance Sheet Information June 30, 2025 Shareholders' equity Preferred stock, 5% cumulative, $50 par value, 97,000 shares authorized, 24,250 shares issued and outstanding Common stock, $1 par, 9,900,000 shares authorized, 990,000 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity The following transactions have also occurred at Crane. $1,020,000 5,020,000 6,120,000 $12,160,000 $1,212,500 990,000 4,050,000 5,980,000 $12,232,500 1. Options were granted on July 1, 2024, to purchase 220,000 shares at $15 per share. Although no options were exercised during fiscal year 2025, the average price per common share during fiscal year 2025 was $20 per share. 2. Each bond was issued at face value. The 9% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2024. 3. The preferred stock was issued in 2024. 4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2025. 5. The 990,000 shares of common stock were outstanding for the entire 2025 fiscal year. 6. Net income for fiscal year 2025 was $1,480,000, and the average income tax rate is 20%. For the fiscal year ended June 30, 2025, calculate the following for Crane Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share $ b. Diluted earnings per share. Diluted earnings per share $ Current Attempt in Progress Amy Dyken, controller at Crane Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Crane's financial statements. Below is selected financial information for the fiscal year ended June 30, 2025. Long-term debt Notes payable, 11% 9% convertible bonds payable 11% bonds payable Total long-term debt Crane Pharmaceutical Industries Selected Balance Sheet Information June 30, 2025 Shareholders' equity Preferred stock, 5% cumulative, $50 par value, 97,000 shares authorized, 24,250 shares issued and outstanding Common stock, $1 par, 9,900,000 shares authorized, 990,000 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity The following transactions have also occurred at Crane. $1,020,000 5,020,000 6,120,000 $12,160,000 $1,212,500 990,000 4,050,000 5,980,000 $12,232,500 1. Options were granted on July 1, 2024, to purchase 220,000 shares at $15 per share. Although no options were exercised during fiscal year 2025, the average price per common share during fiscal year 2025 was $20 per share. 2. Each bond was issued at face value. The 9% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2024. 3. The preferred stock was issued in 2024. 4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2025. 5. The 990,000 shares of common stock were outstanding for the entire 2025 fiscal year. 6. Net income for fiscal year 2025 was $1,480,000, and the average income tax rate is 20%. For the fiscal year ended June 30, 2025, calculate the following for Crane Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share $ b. Diluted earnings per share. Diluted earnings per share $
Expert Answer:
Answer rating: 100% (QA)
a Basic earning per share can be computed as Net income Preferred dividends Weighted Average Shares ... View the full answer
Related Book For
Intermediate Accounting
ISBN: 978-0470423684
13th Edition
Authors: Donald E. Kieso, Jerry J. Weygandt, And Terry D. Warfield
Posted Date:
Students also viewed these accounting questions
-
Downtime in virtually any business can be costly. In a manufacturing setting, it means less product produced in a given time period while still having to pay the bills. This might mean late...
-
Amy Dyken, controller at Fitzgerald Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for...
-
The friction at sleeve A can provide a maximum resisting moment of 125 N ? m about the x axis. Determine the largest magnitude of force F that can be applied to the bracket so that the bracket will...
-
The rate of change of the monthly sales of a newly released football game is given by S'(t) = 500t1/4 S(0) = 0 where t is the number of months since the game was released and S{t)is the number of...
-
What are the "3 15"and why are these essential to learning in the classroom?
-
The data in Exercise 2.175. Use technology to find the correlation for the data indicated. Data From Exercise 2.175: Make a scatterplot of the data. Put the $X$ variable on the horizontal axis and...
-
Water Technology, Inc. incurred the following costs during 20x1. The company sold all of its products manufactured during the year. Direct material...
-
A block placed under the head of the claw hammer as shown greatly facilitates the extraction of the nail. If a 47-lb pull on the handle is required to pull the nail, calculate the tension T in the...
-
Pretend that you were a lab technician. You were assigned to prepare 100 mL of 0.200 M acetate buffer at pH 5.00. Describe in detail how you would make this buffer solution starting from pure solid...
-
Consider the following cash flow profile and assume MARR is 10 percent/year. a. Determine the IRR(s) for this project. b. Is this project economically attractive? EOY 0 1 2 3 4 5 6 NCF -$101 $411...
-
The IRR of this investment is located at which point? a. A b. C c. D d. E
-
An asset has the estimated salvage values for various lives, shown in the table below. For each possible life from 1 to 6 by 1, determine the capital recovery cost for MARR of 8 percent/year. EOY NCF...
-
Refer to the information in QS 13-4. Use that information for Tide Corporation to determine the 2016 and 2017 common-size percents for cost of goods sold using net sales as the base. Data From QS...
-
An engineer prepares a report to evaluate a project using PW and IRR. Just before submitting the report, he spills coffee on it, making the first digit of the 2-digit IRR unreadable. The second digit...
-
Suppose that a company buys about $81,000 worth of items from a vendor each year. If ordering cost is $25 per order and holding cost rate is 20%, how many dollars worth of items should be bought in...
-
Explain the operation of the dividends received deduction.
-
True or False: Benefits and disbenefits must be converted to monetary values to use benefit-cost analysis.
-
Using an Internet-based search on 'build operate transfer," find an additional definition from a source other than used in Section 14.2. Copy and paste it, as well as any graphics, examples,...
-
Elm City is considering a replacement for its police radio. The benefits and costs of the replacement are shown below. What is the replacement's benefit/cost ratio if the effective annual interest...
Study smarter with the SolutionInn App